Implicity ILR ECG Analyzer vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Implicity ILR ECG Analyzer
by Implicity
VS
Zio AT ECG Monitoring System
by iRhythm Technologies, Inc.

AI Verdict

Implicity focuses on optimizing the management and analysis of data from existing cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), streamlining workflows and reducing false positives. In contrast, the Zio AT system provides a proprietary wearable patch for continuous, long-term mobile cardiac telemetry (MCT) to detect arrhythmias. While both utilize AI for cardiac monitoring and reporting, Implicity targets implanted device management, whereas Zio AT offers a self-contained wearable diagnostic service.

Choose Implicity ILR ECG Analyzer if…

Choose Implicity ILR ECG Analyzer if your cardiology practice manages a high volume of patients with existing cardiac implantable electronic devices (CIEDs) or implantable loop recorders (ILRs). This AI-powered platform excels at centralizing data from various device types, significantly reducing false positive alerts, and automating complex billing and reporting workflows for remote monitoring programs.

View Implicity ILR ECG Analyzer →

Choose Zio AT ECG Monitoring System if…

Choose Zio AT ECG Monitoring System if you need a convenient, long-term external wearable solution for continuous ECG monitoring to diagnose or assess transient arrhythmias. This system is ideal for patients requiring up to 14 days of uninterrupted recording with real-time data transmission, providing comprehensive reports powered by FDA-cleared AI for accurate arrhythmia detection.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Implicity ILR ECG Analyzer Zio AT ECG Monitoring System
Pricing Contact vendor for pricing information. Contact for pricing
Deployment Cloud-based / SaaS Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio AT ECG Monitoring System

Tool B, the Zio AT ECG Monitoring System, demonstrates superior patient-centric usability with its discreet, wearable patch and dedicated patient mobile app, MyZio, which has received a 2024 Good Design Award for its user-centered design. Patients report it as easy to wear and use, offering improved comfort and convenience compared to traditional monitors, which directly enhances compliance.

Clinical Value

Implicity ILR ECG Analyzer

While both tools offer significant clinical benefits, Implicity ILR ECG Analyzer (Tool A) provides more quantifiable and impactful outcomes, including a 26% reduction in mortality and a decrease in heart failure hospitalizations, as demonstrated in a nationwide study. It also significantly reduces clinician workload by cutting false positives by 79% for Medtronic ILRs and decreasing unnecessary AF alerts by 85%, allowing for more focused and efficient care.

Pricing & Value

Implicity ILR ECG Analyzer

Both tools require direct contact for pricing, but Tool A, Implicity ILR ECG Analyzer, offers a clear value-add through its 'Dynamic Billing Engine' that achieves over 90% billing compliance and has demonstrated a significant positive impact on practice revenue by capturing missing reports and billable events. This feature directly addresses a critical financial aspect for healthcare providers beyond the core monitoring service.

Enterprise Readiness

Implicity ILR ECG Analyzer

Both tools are cloud-based, FDA-cleared, HIPAA compliant, and have BAAs. However, Implicity ILR ECG Analyzer (Tool A) offers superior enterprise readiness by centralizing and standardizing data from all major cardiac implantable device manufacturers into a single, unified platform. This vendor-agnostic approach, coupled with integration capabilities for over 80 Electronic Health Record (EHR) platforms and ISO 27001 certification, provides a more robust solution for complex healthcare systems.

Innovation

Implicity ILR ECG Analyzer

While Tool B's wearable patch is innovative, Tool A, Implicity ILR ECG Analyzer, demonstrates a more advanced application of AI by specifically targeting and significantly reducing false positives (79%) and unnecessary AF alerts (85%) from existing implantable devices. Its ability to act as an agnostic second-layer filter for manufacturer-embedded AI further highlights its innovative approach to optimizing data interpretation and clinical workflow.

Support & Docs

Implicity ILR ECG Analyzer

Implicity (Tool A) provides a comprehensive 'Customer Success team' that offers structured onboarding, tailored training for various staff profiles, ongoing support, and regular activity reviews to ensure optimal platform utilization. This proactive and dedicated approach to customer success, including change management, goes beyond standard customer care hotlines and documentation offered by Tool B.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Implicity ILR ECG Analyzer Zio AT ECG Monitoring System
Product Name Implicity ILR ECG Analyzer Zio AT ECG Monitoring System
Company Implicity iRhythm Technologies, Inc.
Core Functionality AI-powered platform for remote monitoring of cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows. Wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Primary AI Application Reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity; filters alerts with FDA-cleared algorithms. FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection.
Monitoring Device/Method Analyzes data from cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs). Wearable Zio AT patch for continuous ECG recording (up to 14 days) with wireless gateway.
Key Workflow/Reporting Aspect Automates billing workflows and reporting; provides real-time access; dynamic billing engine for 90%+ billing compliance. Comprehensive end-of-wear reports for clinicians; ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation.

Videos

Demos, reviews, and walkthroughs featuring Implicity ILR ECG Analyzer and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Implicity ILR ECG Analyzer is designed for remote monitoring of cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), centralizing and standardizing data from these implanted devices. In contrast, the Zio AT ECG Monitoring System is a wearable mobile cardiac telemetry (MCT) service that uses a proprietary Zio AT patch for continuous, external ECG recording for up to 14 days.
Implicity's AI-powered ILR ECG Analyzer reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity and leads to an 85% decrease in unnecessary AF alerts by filtering clinically relevant events. The Zio AT system utilizes an FDA-cleared deep-learned AI algorithm (ZEUS System) for continuous arrhythmia detection from its wearable patch, identifying both symptomatic and asymptomatic cardiac events.
Implicity offers smart workflow automation including real-time access, automated billing workflows and reporting, and patient connectivity management with automated SMS to reconnect disconnected patients. The Zio AT system provides a ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation, along with comprehensive end-of-wear reports for clinicians.
Yes, Implicity's platform explicitly features 'Unified Device Data,' which centralizes and standardizes all cardiac implantable device data. The Zio AT system, on the other hand, is a self-contained monitoring service centered around its proprietary Zio AT patch and associated data analysis.
Implicity includes automated SMS to reconnect 28% of disconnected patients within two days, enhancing patient connectivity management. The Zio AT system offers the MyZiou00ae patient mobile app for symptom logging and patient education, empowering patients to participate in their monitoring process.
The Zio AT ECG Monitoring System provides continuous, uninterrupted ECG recording for up to 14 days using its wearable patch. Implicity's platform remotely monitors existing cardiac implantable electronic devices and implantable loop recorders, which are typically long-term implanted devices.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Implicity ILR ECG Analyzer or Zio AT ECG Monitoring System

Backers

Who funded each tool's parent company.

Implicity ILR ECG Analyzer

Zio AT ECG Monitoring System

AI Tool Finder
AI-powered search. Results may not be comprehensive.